James F Oliviero III insider trades: Checkpoint Therapeutics (CKPT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
47 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 2, 2025 | CKPT | ↓ Sell | 15,090 | $4.04 | $61K | Direct | Apr 3, 2025 (1d) |
| Feb 10, 2025 | CKPT | ↓ Sell | 19,564 | $3.27 | $64K | Direct | Feb 11, 2025 (1d) |
| Dec 19, 2024 | CKPT | ↓ Sell | 822,397 | $3.74 | $3.1M | Direct | Dec 20, 2024 (1d) |
| Jun 26, 2024 | CKPT | ↓ Sell | 24,610 | $2.05 | $50K | Direct | Jun 28, 2024 (2d) |
| Feb 28, 2024 | CKPT | ↓ Sell | 5,894 | $2.06 | $12K | Direct | Mar 1, 2024 (2d) |
| Feb 1, 2024 | CKPT | ↓ Sell | 11,900 | $2.01 | $24K | Direct | Feb 2, 2024 (1d) |
| Mar 2, 2023 | CKPT | ↓ Sell | 11,031 | $4.82 | $53K | Direct | Mar 3, 2023 (1d) |
| Feb 1, 2023 | CKPT | ↓ Sell | 10,261 | $4.77 | $49K | Direct | Feb 3, 2023 (2d) |
| Jan 10, 2023 | CKPT | ↓ Sell | 3,817 | $6.75 | $26K | Direct | Jan 12, 2023 (2d) |
| Jun 23, 2022 | CKPT | ↓ Sell | 276,000 | $1.09 | $301K | Direct | Jul 1, 2022 (8d) |
| Apr 13, 2022 | CKPT | ↓ Sell | 121,641 | $1.74 | $212K | Direct | Apr 22, 2022 (9d) |
| Feb 5, 2021 | CKPT | ↓ Sell | 118,790 | $3.47 | $412K | Direct | Feb 5, 2021 (0d) |
| Jul 6, 2015 | KERX | ↓ Sell | 1,943 | $9.61 | $19K | Direct | Jul 8, 2015 (2d) |
| Apr 6, 2015 | KERX | ↓ Sell | 1,878 | $11.68 | $22K | Direct | Apr 8, 2015 (2d) |
| Jan 5, 2015 | KERX | ↓ Sell | 5,604 | $13.79 | $77K | Direct | Jan 6, 2015 (1d) |
| Dec 10, 2014 | KERX | ↓ Sell | 25,000 | $15.69 | $392K | Direct | Dec 12, 2014 (2d) |
| Oct 3, 2014 | KERX | ↓ Sell | 2,694 | $16.14 | $43K | Direct | Oct 7, 2014 (4d) |
| Sep 8, 2014 | KERX | ↓ Sell | 144,237 | $15.88 | $2.3M | Direct | Sep 10, 2014 (2d) |
| Jul 7, 2014 | KERX | ↓ Sell | 2,054 | $15.75 | $32K | Direct | Jul 9, 2014 (2d) |
| Apr 3, 2014 | KERX | ↓ Sell | 2,087 | $16.46 | $34K | Direct | Apr 7, 2014 (4d) |
| Mar 21, 2014 | KERX | ↓ Sell | 292,483 | $15.14 | $4.4M | Direct | Mar 21, 2014 (0d) |
| Jan 3, 2014 | KERX | ↓ Sell | 6,309 | $12.57 | $79K | Direct | Jan 6, 2014 (3d) |
| Dec 30, 2013 | KERX | ↓ Sell | 109,500 | $12.64 | $1.4M | Direct | Dec 31, 2013 (1d) |
| Oct 3, 2013 | KERX | ↓ Sell | 1,475 | $10.25 | $15K | Direct | Oct 7, 2013 (4d) |
| Jul 5, 2013 | KERX | ↓ Sell | 1,438 | $7.95 | $11K | Direct | Jul 9, 2013 (4d) |
| May 13, 2013 | KERX | ↓ Sell | 29,363 | $8.34 | $245K | Direct | May 14, 2013 (1d) |
| Apr 5, 2013 | KERX | ↓ Sell | 1,484 | $6.93 | $10K | Direct | Apr 8, 2013 (3d) |
| Jan 4, 2013 | KERX | ↓ Sell | 10,859 | $2.74 | $30K | Direct | Jan 4, 2013 (0d) |
| Oct 3, 2012 | KERX | ↓ Sell | 4,973 | $2.72 | $14K | Direct | Oct 5, 2012 (2d) |
| Jul 3, 2012 | KERX | ↓ Sell | 4,559 | $1.99 | $9K | Direct | Jul 6, 2012 (3d) |
| Apr 5, 2012 | KERX | ↓ Sell | 5,458 | $1.60 | $9K | Direct | Apr 5, 2012 (0d) |
| Jan 3, 2012 | KERX | ↓ Sell | 7,190 | $2.63 | $19K | Direct | Jan 3, 2012 (0d) |
| Oct 3, 2011 | KERX | ↓ Sell | 6,105 | $2.82 | $17K | Direct | Oct 5, 2011 (2d) |
| Jul 5, 2011 | KERX | ↓ Sell | 4,611 | $4.80 | $22K | Direct | Jul 7, 2011 (2d) |
| Jun 6, 2011 | KERX | ↓ Sell | 47,231 | $4.99 | $236K | Direct | Jun 8, 2011 (2d) |
| Apr 5, 2011 | KERX | ↓ Sell | 4,490 | $5.10 | $23K | Direct | Apr 7, 2011 (2d) |
| Jan 3, 2011 | KERX | ↓ Sell | 14,064 | $4.67 | $66K | Direct | Jan 3, 2011 (0d) |
| Dec 6, 2010 | KERX | ↓ Sell | 135,373 | $5.02 | $679K | Direct | Dec 6, 2010 (0d) |
| Oct 4, 2010 | KERX | ↓ Sell | 1,209 | $4.58 | $6K | Direct | Oct 6, 2010 (2d) |
| Aug 20, 2010 | KERX | ↓ Sell | 10,000 | $3.84 | $38K | Direct | Aug 20, 2010 (0d) |
| Jul 6, 2010 | KERX | ↓ Sell | 1,213 | $3.35 | $4K | Direct | Jul 8, 2010 (2d) |
| Jun 8, 2010 | KERX | ↓ Sell | 41,497 | $3.96 | $165K | Direct | Jun 10, 2010 (2d) |
| May 12, 2010 | KERX | ↓ Sell | 60,000 | $6.26 | $376K | Direct | May 14, 2010 (2d) |
| Apr 5, 2010 | KERX | ↓ Sell | 899 | $3.36 | $3K | Direct | Apr 7, 2010 (2d) |
| Jan 5, 2010 | KERX | ↓ Sell | 22,981 | $2.60 | $60K | Direct | Jan 5, 2010 (0d) |
| Jun 23, 2009 | KERX | ↑ Buy | 2,750 | $0.90 | $2K | Direct | Jun 23, 2009 (0d) |
| May 22, 2009 | KERX | ↑ Buy | 25,000 | $0.40 | $10K | Direct | May 22, 2009 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About James F Oliviero III's insider trades
James F Oliviero III is CEO, President and Director at Checkpoint Therapeutics (CKPT). Since May 22, 2009, James has reported 2 open-market purchases worth $12K and 45 sales worth $15.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (26 filings), option exercises (5 filings), gifts (4 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CKPT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.